Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2006
10/04/2006CN1277822C Quinazoline derivatives, pharmaceutical composition containing the compound, their utilization and preparation method thereof
10/04/2006CN1277543C Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses
10/04/2006CN1277537C Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
10/04/2006CN1277532C Pearl powder soft capsule
10/03/2006US7115758 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
10/03/2006US7115739 Triazole compounds useful as protein kinase inhibitors
10/03/2006US7115729 Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53
10/03/2006US7115725 Polypeptide for use in the generation of vaccine against diphtheria toxin
10/03/2006US7115720 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain)
10/03/2006US7115637 Inhibitors of p38
10/03/2006US7115635 Benzylpiperidine compound
10/03/2006US7115623 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction
10/03/2006US7115622 Amido ether substituted imidazoquinolines
10/03/2006US7115621 Chemical compounds
10/03/2006US7115602 Antiinflammatory agents; respiratory system disorders; autoimmune disease
10/03/2006US7115589 Phosphorus-containing moietys; kinase inhibitors; improve balance of bone growth relative to bone resorption; inhibit PTH-induced bone resorption; cytotoxic or growth inhibitory effect on cancer cell lines
10/03/2006US7115585 Compositions for treating epithelial and retinal tissue diseases
10/03/2006US7115579 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
10/03/2006US7115395 DNAs encoding guinea pig histamine receptors of the H4 subtype
10/03/2006US7115373 Diagnosing allergies via measuring expression of nuclear orphan receptor (NOR-1 receptor) gene; identifying modulators for treating atopic dermatitis
10/03/2006US7115268 Peptides derived from homologous sequences of the family of staphylococcal and streptococcal toxins, which may be polymeric, that provide protection against, or reduce the severity of toxic shock and septic shock from bacterial infections
10/03/2006US7115267 polypeptide comprising hemoglobin alpha chain wherein the C-terminal hydrophobic domain has been substituted or deleted; regulating stem cell cycle and accelerating the post-chemotherapy peripheral blood cell recovery; inhibitors and stimulators of stem cell proliferation.
10/03/2006US7115250 Heating erectile dysfunction drug to vaporize; cooling to form condensation aerosol; drug delivery
10/03/2006US7114966 Apparatus for a quick release safety connector assembly
10/03/2006CA2346438C Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
10/03/2006CA2288241C Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
10/03/2006CA2250906C Enteric-coated pharmaceutical compositions of mycophenolate
10/03/2006CA2249348C Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
10/03/2006CA2215319C Compositions comprising nicotinylalanine and an inhibitor of glycine conjugation or vitamin b6
10/03/2006CA2212440C Pharmaceutical preparations for tnf inhibition
09/2006
09/28/2006WO2006101860A1 Novel thiophene sulfoximines for treating complement-mediated diseases and conditions
09/28/2006WO2006101454A1 Benzothiophene derivatives: preparation and pharmaceutical applications
09/28/2006WO2006100633A1 NOVEL THIOPHENE DERIVATIVES AS SPHINGOSINE-l-PHOSPHATE-1 RECEPTOR AGONISTS
09/28/2006WO2006100631A1 Hydrogenated benzo (c) thiophene derivatives as immunomodulators
09/28/2006WO2006099875A1 Antibodies against cd38 for treatment of multiple myeloma
09/28/2006WO2006099681A1 Isoflavonoid dimers
09/28/2006WO2006067867A8 Cell adhesion factor expression inhibitor
09/28/2006WO2006015861A3 Drop preparations comprising dimetindene
09/28/2006WO2002008267A9 Compounds and methods for treatment and diagnosis of chlamydial infection
09/28/2006US20060217557 Polymorphic form XVI of fexofenadine hydrochloride
09/28/2006US20060217556 Benzoxepino-11-piperidylidene compounds and process for production thereof
09/28/2006US20060217551 (3R,4R)-1-[(9-deazahypoxanthin-9-yl)methyl]-3-hydroxy-4-hydroxymethyl-pyrrolidine; reaction of formaldehydewith a cyclic amine and a heteroaromatic compound to give methylene linked cyclic amine deazapurines; cancer, bacterial, protozoal infections or T-cell mediated diseases
09/28/2006US20060217531 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
09/28/2006US20060217530 Active against C5a receptors on polymorphonuclear leukocytes and macrophages; peptidomimetics; for treatment of inflammation
09/28/2006US20060217429 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril
09/28/2006US20060217411 2-Phenyl- pyrazoloquinolin-3-ones and pyrazolo(thio)chromen-3-ones, e.g., N-[4-(6-Fluoro-3-oxo-3,5-dihydropyrazolo[4,3-c]quinolin-2-yl)-phenyl]-2-methyl-butyramide; used to treat rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis and psoriasis
09/28/2006US20060217407 Compositions and Formulations of 9-Nitrocamptothecin Polymorphs and Methods of Use Therefor
09/28/2006US20060217406 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents
09/28/2006US20060217388 Phthalazine derivatives for treating inflammatory diseases
09/28/2006US20060217364 Beta-lactamyl vasopressin V1a antagonists
09/28/2006US20060217353 24-sulfoximine vitamin D3 compounds
09/28/2006US20060217348 Pyrazolo[1,5-a] pyridines and medicines containing the same
09/28/2006US20060217339 Breast cancer, prostate cancer, brain cancer, head and neck cancer, myeloma, melanoma, leukemia and lymphoma; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools.
09/28/2006US20060217309 Novel cyclosporine analog formulations
09/28/2006US20060217297 Dimerized peptide
09/28/2006US20060216777 Immobilization on solid support
09/28/2006US20060216317 Delivery of polynucleotide agents to the central nervous system
09/28/2006US20060216244 Delivery of compounds for the treatment of parkinson's through an inhalation route
09/28/2006US20060216243 Delivery of Beta-Blockers Through An Inhalation Route
09/28/2006DE19917195B4 Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor Peptide to induce an immune response against tumor cells containing this pharmzeutische compositions, uses thereof, nucleic acid coding therefor and these nucleic acid expression vector containing
09/28/2006DE102005012971A1 Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure Polymorphic form of 6- (4-chlorophenyl) -2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-acetic acid
09/28/2006CA2602541A1 Isoflavonoid dimers
09/28/2006CA2602478A1 Novel thiophene derivatives
09/28/2006CA2602475A1 Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
09/28/2006CA2602474A1 Hydrogenated benzo (c) thiophene derivatives as immunomodulators
09/28/2006CA2602375A1 Antibodies against cd38 for treatment of multiple myeloma
09/28/2006CA2601523A1 Novel thiophene sulfoximines for treating complement-mediated diseases and conditions
09/28/2006CA2600531A1 Pyrimidine compounds and methods of use
09/27/2006EP1705487A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
09/27/2006EP1705182A1 Antitumoral and antiviral peptides
09/27/2006EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists
09/27/2006EP1704863A2 Combination comprising N-5-4-(4-Methyl-Piperazino-Methyl-)Benzoyla Mido]-2-Methylphenyl -4-(3-Pyridyl)-2Phyrimidine-amine and a chemotherapeutic agent
09/27/2006EP1704855A2 2-Cyclopenten-1-one and its Derivatives as Inhibitors of the NF-kappa B Factor
09/27/2006EP1704145A1 Selective kinase inhibitors
09/27/2006EP1703906A1 Immuno inhibitory pyrazolone compounds
09/27/2006EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators
09/27/2006EP1511496B1 Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
09/27/2006EP1461062B1 Composition and method for treating chronic allograft rejection
09/27/2006EP1395590B1 Dihydropyrrolo¬1,2-a|indole and tetrahydropyrido¬1,2-a|indole derivatives as prostaglandin d2 receptor antagonists
09/27/2006EP1383757B1 Antagonists of mcp-1 function and methods of use thereof
09/27/2006EP1337521B1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
09/27/2006EP1268759B1 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant
09/27/2006CN1839202A Process for producing cytotoxic lymphocytes
09/27/2006CN1839133A Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
09/27/2006CN1838965A Drug for cancer therapy
09/27/2006CN1837231A Immunomodulatory steroids, in particular the hemihydrate of 16, alpha-bromoepiandrosterone
09/27/2006CN1836686A Chinese traditional effective part compound preparation for promoting organic body immune function, and its preparation method
09/27/2006CN1836684A Silktree albizzia general saponin and its extraction method, pharmaceutical use of the said composition and medicine preparation
09/27/2006CN1836679A Tablet spirulina spp for invigorating yang , and its preparation method
09/27/2006CN1836676A Method for preparing and controlling the quality of lucid ganoderma spore powder soft capsule
09/27/2006CN1836675A Tablet containing lucid ganoderma and spirulina spp. ,and its preparation method
09/27/2006CN1836674A Antler lucid ganoderma and its extract for preparing pharmaceutical and food for treating cancer and immunity effect
09/27/2006CN1836562A Production method of gastrodia elata nutritious dilated food series
09/27/2006CN1276969C Liquor prepared from traditional medicine and process for its preparation
09/26/2006US7112660 Modified cytokine
09/26/2006US7112603 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
09/26/2006US7112597 5-(Substituted thiazolylethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases
09/26/2006US7112594 A N-phenyl-benzo(b)thiophene-carboxamide derivatives, as enzyme inhibitor of tyrosine kinase; antiproliferation of lymphocyte, treating autoimmune disease, rheumatic disease, as immunosuppressant, antiinflammatory agents
09/26/2006US7112589 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
09/26/2006US7112580 3-nitrogen-6, 7-dioxygen steroids and uses related thereto